Рынок гиалуроновой кислоты в Азиатско-Тихоокеанском регионе – тенденции отрасли и прогноз до 2030 года

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Рынок гиалуроновой кислоты в Азиатско-Тихоокеанском регионе – тенденции отрасли и прогноз до 2030 года

  • Pharmaceutical
  • Published Report
  • Jan 2023
  • Asia-Pacific
  • 350 Pages
  • Количество таблиц: 505
  • Количество рисунков: 39

Asia Pacific Hyaluronic Acid Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
2024 –2030
Diagram Размер рынка (базовый год)
МИЛЛИОН ДОЛЛАРОВ США
Diagram Размер рынка (прогнозируемый год)
USD 2,584.42
Diagram CAGR
%
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Рынок гиалуроновой кислоты в Азиатско-Тихоокеанском регионе по классу (косметический и фармацевтический класс), типу (гидролизованная гиалуроновая кислота, ацетилированная гиалуроновая кислота натрия и гиалуронат натрия), применению (эстетика, остеоартрит, фармацевтические АФИ, косметика , офтальмология и другие), конечному пользователю (медицинские спа-салоны и косметические центры, дерматологические клиники и центры косметической хирургии), каналу сбыта (прямые тендеры и розничные продажи). Тенденции отрасли и прогноз до 2030 года.

Рынок гиалуроновой кислоты

Анализ и информация о рынке гиалуроновой кислоты в Азиатско-Тихоокеанском регионе

Гиалуроновая кислота используется в основном в косметических средствах и средствах по уходу за кожей. Она обеспечивает быстрое заживление ран, уменьшает морщины на лице, морщины и старение кожи, а также лечит порезы и ожоги, среди прочего. Она содержит витамин С для осветления тона кожи. Косметические средства, содержащие гиалуроновую кислоту, питают кожу, когда применяются в виде увлажняющих средств, кремов, тоников для кожи и сывороток, среди прочего.

Рынок гиалуроновой кислоты

Рынок гиалуроновой кислоты

По данным исследования Data Bridge Market Research, ожидается, что рынок гиалуроновой кислоты в Азиатско-Тихоокеанском регионе будет расти среднегодовыми темпами на 7,3% в прогнозируемый период с 2023 по 2030 год и достигнет 2 584,42 млн долларов США к 2030 году.

Отчет Метрика

Подробности

Прогнозируемый период

2023-2030

Базовый год

2022

Исторические годы

2021 (можно настроить на 2020-2016)

Количественные единицы

Доход в млн. долл. США

Охваченные сегменты

По классу (косметический и фармацевтический класс), типу (гидролизованная гиалуроновая кислота, ацетилированная гиалуроновая кислота натрия и гиалуронат натрия), применению (эстетика, остеоартрит, фармацевтические АФИ, косметика, офтальмология и другие), конечному пользователю (медицинские спа-салоны и косметические центры, дерматологические клиники и центры косметической хирургии), каналу сбыта (прямые тендеры и розничные продажи).

Страны, охваченные

Япония, Китай, Южная Корея, Индия, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Филиппины и остальные страны Азиатско-Тихоокеанского региона.

Охваченные участники рынка

Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED, Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals, принадлежащая Oceania International LLC, Bioiberica SAU, GENESIS Pharmacy Services и Brickell Men's Products среди прочих

Определение рынка

Гиалуроновая кислота (ГК), также называемая гиалуронаном, представляет собой анионный, несульфатированный гликозаминогликан, широко распространенный в соединительной, эпителиальной и нервной тканях. Являясь важным компонентом суставного хряща, гиалуроновая кислота окружает каждую клетку хряща подобно оболочке (хондроциту). Прочность хряща обусловлена ​​поглощением воды этими агрегатами (ее устойчивостью к сжатию). Молекулярная масса (размер) гиалуронана в хряще уменьшается с возрастом, но его количество увеличивается. Человеческое тело естественным образом содержит ГК. Наибольшее количество ГК наблюдается в суставах и глазах. Это химическое вещество обладает способностью поддерживать сочную, увлажненную кожу. В результате многие косметические хирурги используют его в качестве инъекционного препарата для замедления признаков старения кожи.

Растущая распространенность минимально инвазивных процедур и растущая осведомленность и спрос на гиалуроновую кислоту в фармацевтических и косметических продуктах по всему миру являются основными движущими факторами роста рынка в прогнозируемый период. Резкий рост качества исследований в сочетании с ростом исследовательских возможностей обусловлен различными стратегическими инициативами, предпринятыми участниками рынка. Они предпринимают такие инициативы, как запуск продуктов, сотрудничество, слияния, поглощения и многое другое на протяжении многих лет, и, как ожидается, будут лидировать и создавать больше возможностей на рынке.

Динамика рынка гиалуроновой кислоты в Азиатско-Тихоокеанском регионе

В этом разделе рассматривается понимание движущих сил рынка, преимуществ, возможностей, ограничений и проблем. Все это подробно обсуждается ниже:

ВОДИТЕЛИ

  • Повышение осведомленности о косметических инъекциях или дермальных наполнителях

Дермальные наполнители на основе гиалуроновой кислоты являются менее инвазивными косметическими процессами. Дерматологические проблемы распространены во всем мире. Стало серьезной проблемой понимание продуктов для лечения проблем, связанных с кожей, и восстановления морщин на коже. Были запущены различные программы для повышения осведомленности о правильном использовании инъекций гиалуроновой кислоты.

Повышение уровня сознательности позволит потребителям выбирать правильное лечение акне и морщин и выбирать правильный продукт (инъекции ботокса, дермальные наполнители) в соответствии с правильной причиной. Это приведет к росту продаж, увеличению портфеля продуктов и расширению линейки продуктов. Ожидается, что этот фактор будет способствовать росту рынка.

  • Использование инвазивных дермальных филлеров на основе гиалуроновой кислоты

Дермальные наполнители на основе гиалуроновой кислоты — это менее инвазивные косметические процессы, которые стремительно распространяются по всему миру. Это популярные косметические процедуры для обновления лица, восстановления объема лица и эстетического улучшения.

Они довольно универсальны и используются на тонких линиях и морщинах. Кроме того, они также используются для лечения акне, морщин и шрамов, а также для увеличения губ, щек и подбородка. Рост гериатрического населения повысил необходимость неинвазивных хирургических протоколов.

Внедрение дермальных филлеров на основе гиалуроновой кислоты снизит шансы выбора обычной хирургии. Существует минимальная стоимость лечения, и этот фактор будет стимулировать рост рынка.

ОГРАНИЧЕНИЯ

  • Наличие несанкционированных или альтернативных дермальных наполнителей затрудняет развитие рынка

Учитывая широкую доступность эстетического применения дермальных филлеров на основе гиалуроновой кислоты, прогнозируется, что ряд ограничивающих факторов, связанных с этими продуктами, будут сдерживать рост рынка Азиатско-Тихоокеанского региона в ближайшие годы.

Благодаря высокой эффективности, удовлетворенности пациентов и использованию при динамических морщинах дермальный наполнитель на основе ботулотоксина является лидером среди нехирургических косметических процедур во всем мире.

Кроме того, другие биоразлагаемые наполнители, такие как гидроксиапатит кальция (CaHA) и поли-L-молочная кислота, набирают популярность в качестве альтернативных наполнителей, используемых в качестве имплантатов с высокой долговечностью.

Было отмечено нежелание врачей использовать дешевые нелегальные продукты из-за связанных с этим рисков. И наоборот, нелегальные продукты, доступные в сегменте дермальных наполнителей, увеличат конкуренцию в цене, особенно в сегменте гиалуроновой кислоты. Более крупные компании, предлагающие высокие цены за единицу, имеют возможность конкурировать, предлагая несколько наборов продуктов и продавая продукты среди различных продуктовых подразделений.

Чтобы компенсировать более низкие цены на дермальные филлеры на основе гиалуроновой кислоты, производителям частиц и полимеров придется продвигать продукцию. Продукция, доступная в сегменте, различается. Производители будут больше ориентироваться на прочность материала, используемого в дермальных филлерах, а не на себестоимость.

ВОЗМОЖНОСТИ

  • Новые технологии и разработки в области продуктов на основе гиалуроновой кислоты

Передовые инновационные технологии улучшили эстетическое лечение кожи и других частей тела везде, где это необходимо, и индустрия ухода за кожей является одной из самых быстро меняющихся. Домашние бренды с активными веществами, уход за кожей на основе ингредиентов и сфера красоты наблюдают рост инвестиций, и потребитель активно участвует. Передовые инновационные технологии и разработки продуктов на основе гиалуроновой кислоты повышают спрос на гиалуроновую кислоту на рынке.

Гиалуроновые дермальные продукты основаны на гиалуроновой кислоте, которая корректирует недостатки лица, компенсирует объем и подчеркивает определенные области лица. Прогресс в дермальных продуктах предлагает эффективный способ улучшения, восстановления и определения черт лица. Прогресс в продуктах на основе гиалуроновой кислоты и процедурах дермальных наполнителей привлекает клиентов к косметике. Таким образом, это означает, что технологический прогресс в гиалуроновых дермальных продуктах, как ожидается, будет выступать в качестве возможности для роста рынка.

ВЫЗОВЫ

  • Растущий отзыв продукции

Отзыв продукции на основе гиалуроновой кислоты оказал значительное влияние на рост рынка. Регулирующие органы отзывают эстетическую и косметическую продукцию из-за проблем со здоровьем и безопасностью. В каждой стране есть свой регулирующий орган, который отвечает за контроль регулирования продукции, связанной со здравоохранением.

Отзыв продукции компаниями или регулирующими органами из-за проблем, связанных с безопасностью для здоровья пациентов, таких как неточность состава или ошибка в ингредиентах, — это лишь некоторые из основных проблем, которые представляют собой вызов росту рынка, поскольку безопасность и здоровье пациента являются важнейшими критериями для любого рынка, выводящего на рынок свою продукцию.

Последние события

  • В феврале 2022 года компания Allergan (дочерняя компания AbbVie Inc.) объявила об одобрении FDA препарата JUVÉDERM VOLBELLA XC для коррекции подглазничных впадин у взрослых старше 21 года. Это помогло компании расширить свой ассортимент эстетической продукции на рынке США.
  • В феврале 2021 года компания Contipro, известный производитель гиалуроновой кислоты из Чешской Республики, объявила о запуске своего нового средства против старения и акне под названием HyRetin, которое улучшает видимость кожи.

Масштаб рынка гиалуроновой кислоты в Азиатско-Тихоокеанском регионе

Рынок гиалуроновой кислоты в Азиатско-Тихоокеанском регионе сегментирован на пять заметных сегментов на основе сорта, типа, применения, конечного пользователя и канала сбыта. Рост среди этих сегментов поможет вам проанализировать сегменты с незначительным ростом в отраслях и предоставить пользователям ценный обзор рынка и рыночные идеи для принятия стратегических решений по определению основных рыночных приложений.

Оценка

  • Косметический класс
  • Фармацевтический класс

В зависимости от класса рынок сегментирован на косметический и фармацевтический.

Тип

  • Гидролизованная гиалуроновая кислота
  • Гиалуроновая кислота ацетилированная натрием
  • Гиалуронат натрия

По типу рынок сегментирован на гидролизованную гиалуроновую кислоту, натриевую ацетилированную гиалуроновую кислоту и гиалуронат натрия.

Приложение

  • Эстетика
  • Остеоартрит
  • Фармацевтический API
  • Косметика
  • Офтальмология
  • Другие

По сфере применения рынок сегментирован на эстетическую медицину, остеоартрит, фармацевтические АФИ, косметику, офтальмологию и другие.

Конечный пользователь

  • Фармацевтическая промышленность
  • Дерматологические клиники
  • Центры косметической хирургии
  • Другие

По конечному потребителю рынок сегментируется на фармацевтическую промышленность, дерматологические клиники, центры косметической хирургии и другие.

Канал распространения

  • Прямой тендер
  • Розничные продажи

По каналу сбыта рынок сегментируется на прямые поставки и розничные продажи.

Региональный анализ/информация о рынке гиалуроновой кислоты в Азиатско-Тихоокеанском регионе

Проведен анализ рынка гиалуроновой кислоты в Азиатско-Тихоокеанском регионе, а также предоставлены сведения о размерах рынка и тенденциях по странам, маркам, типам, областям применения, конечным пользователям и каналам сбыта, как указано выше.

В данном отчете о рынке рассматриваются следующие страны: Япония, Китай, Южная Корея, Индия, Австралия, Сингапур, Таиланд, Малайзия, Индонезия, Филиппины и остальные страны Азиатско-Тихоокеанского региона.

  • В 2023 году Япония будет доминировать на рынке гиалуроновой кислоты в Азиатско-Тихоокеанском регионе по доле рынка и выручке и продолжит процветать в течение прогнозируемого периода. Это связано с растущей популярностью нехирургических или минимально инвазивных косметических процедур.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые и заменяющие продажи, демографические данные страны, эпидемиология заболеваний и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность брендов Азиатско-Тихоокеанского региона и их проблемы, связанные с конкуренцией со стороны местных и отечественных брендов, а также влияние каналов продаж.

Анализ конкурентной среды и доли рынка гиалуроновой кислоты в Азиатско-Тихоокеанском регионе

Конкурентная среда рынка гиалуроновой кислоты в Азиатско-Тихоокеанском регионе содержит подробную информацию по конкурентам. Включены следующие сведения: обзор компании, финансовые показатели компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, присутствие в Азиатско-Тихоокеанском регионе, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта и доминирование в применении. Приведенные выше данные относятся только к фокусу компаний на рынке.

Некоторые из основных игроков, работающих на рынке гиалуроновой кислоты в Азиатско-Тихоокеанском регионе, включают Fidia Farmaceutici SpA, AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., LABORATOIRES FILLMED , Prollenium Medical Technologies., Huons, Contipro as, Lifecore Biomedical, Inc., BioScience GmbH, Teoxane, Bioxis Pharmaceuticals, SHANDONG TOPSCIENCE BIOTECH CO., LTD., Bohus BioTech AB, RIVER PHARMA srl, Symatese, Stanford Chemicals, принадлежащая Oceania International LLC, Bioiberica SAU, GENESIS pharmacy services и Brickell Men's Products и другие.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA PACIFIC HYALURONIC ACID MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 GRADE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER'S FIVE FORCES

4.3 NUMBER OF AESTHETIC SURGERY PROCEDURES

4.4 INDUSTRY INSIGHTS

5 REGULATORY FRAMEWORK

5.1 EGULATORY SCENARIO IN THE U.S.

5.2 REGULATORY SCENARIO IN EUROPE

5.3 REGULATORY SCENARIO IN CHINA

5.4 REGULATORY SCENARIO IN AUSTRALIA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING AWARENESS TOWARDS COSMETIC INJECTABLES OR DERMAL FILLERS

6.1.2 USE OF INVASIVE HYALURONIC ACID BASED DERMAL FILLERS

6.1.3 RISE IN PRODUCT APPROVALS

6.1.4 GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES

6.2 RESTRAINTS

6.2.1 AVAILABILITY OF UNAUTHORIZED OR ALTERNATIVE DERMAL FILLERS TO HAMPER MARKET

6.2.2 POOR MEDICAL REIMBURSEMENT POLICIES

6.2.3 SIDE EFFECTS RELATED TO HYALURONIC ACID INJECTION

6.3 OPPORTUNITIES

6.3.1 NEW TECHNOLOGY AND DEVELOPMENTS IN HYALURONIC ACID PRODUCTS

6.3.2 NUTRICOSMETICS HYALURONIC ACID DERMAL FILLERS

6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.4 INCREASING RESEARCH AND DEVELOPMENT

6.4 CHALLENGES

6.4.1 ESCALATING PRODUCT RECALL

6.4.2 LACK OF EXPERTISE

7 ASIA PACIFIC HYALURONIC ACID MARKET, BY GRADE

7.1 OVERVIEW

7.2 COSMETIC GRADE

7.2.1 GENDER

7.2.1.1 FEMALE PRODUCTS

7.2.1.2 MEN’S PRODUCT

7.2.2 PRODUCT TYPE

7.2.2.1 SKIN CARE

7.2.2.2 MAKEUP

7.2.2.3 CLEANSING

7.2.2.4 HAIR CARE

7.2.2.5 OTHERS

7.2.3 PROCEDURE

7.2.3.1 WRINKLE REMOVAL

7.2.3.2 SKIN SMOOTHENING

7.2.3.3 FACE LIFT

7.2.3.4 LIP AUGMENTATION

7.2.3.5 CHIN AUGMENTATION

7.2.3.6 FAT INJECTION

7.2.3.7 FACE LINE CORRECTION

7.2.3.8 ACNE SCAR TREATMENT

7.2.3.9 LIP PLUM

7.2.3.10 EAR LOBE REJUVENATION

7.2.3.11 LIPOATROPHY TREATMENT

7.2.3.12 OTHERS

7.3 PHARMACEUTICAL GRADE

7.3.1 TYPE

7.3.1.1 MEDICAL GRADE HYALURONIC ACID

7.3.1.2 INJECTION GRADE HYALURONIC ACID

7.3.2 PRODUCT TYPE

7.3.2.1 TOPICAL PREPARATIONS

7.3.2.2 INTRA-ARTICULAR INJECTION

7.3.2.2.1 PREFILLED INJECTIONS

7.3.2.2.2 VIAL

7.3.2.3 EYE DROPS

7.3.2.4 ORAL PHARMACEUTICAL PREPARATIONS

7.3.2.5 OTHERS

8 ASIA PACIFIC HYALURONIC ACID MARKET, BY TYPE

8.1 OVERVIEW

8.2 SODIUM HYALURONATE

8.2.1 MOLECULAR WEIGHT

8.2.1.1 HIGH MOLECULAR WEIGHT

8.2.1.2 LOW MOLECULAR WEIGHT

8.2.1.3 MEDIUM MOLECULAR WEIGHT

8.2.2 BY TYPE

8.2.2.1 COSMETIC GRADE

8.2.2.1.1 GENDER

8.2.2.1.1.1 FEMALE PRODUCTS

8.2.2.1.1.2 MEN'S PRODUCT

8.2.2.1.2 PRODUCT TYPE

8.2.2.1.2.1 SKIN CARE

8.2.2.1.2.2 MAKEUP

8.2.2.1.2.3 CLEANSING

8.2.2.1.2.4 HAIR CARE

8.2.2.1.2.5 OTHERS

8.2.2.2 PHARMACEUTICAL GRADE

8.2.2.2.1 TYPE

8.2.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.2.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.2.2.2.2 PRODUCT TYPE

8.2.2.2.2.1 TOPICAL PREPARATIONS

8.2.2.2.2.2 INTRA-ARTICULAR INJECTION

8.2.2.2.2.2.1 PREFILLED INJECTIONS

8.2.2.2.2.2.2 VIAL

8.2.2.2.2.3 EYE DROPS

8.2.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.2.2.2.2.5 OTHERS

8.3 HYDROLYZED HYALURONIC ACID

8.3.1 MOLECULAR WEIGHT

8.3.1.1 HIGH MOLECULAR WEIGHT

8.3.1.2 LOW MOLECULAR WEIGHT

8.3.1.3 MEDIUM MOLECULAR WEIGHT

8.3.2 BY TYPE

8.3.2.1 COSMETIC GRADE

8.3.2.1.1 GENDER

8.3.2.1.1.1 FEMALE PRODUCTS

8.3.2.1.1.2 MEN'S PRODUCT

8.3.2.1.2 PRODUCT TYPE

8.3.2.1.2.1 SKIN CARE

8.3.2.1.2.2 MAKEUP

8.3.2.1.2.3 CLEANSING

8.3.2.1.2.4 HAIR CARE

8.3.2.1.2.5 OTHERS

8.3.2.2 PHARMACEUTICAL GRADE

8.3.2.2.1 TYPE

8.3.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.3.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.3.2.2.2 PRODUCT TYPE

8.3.2.2.2.1 TOPICAL PREPARATIONS

8.3.2.2.2.2 INTRA-ARTICULAR INJECTION

8.3.2.2.2.2.1 PREFILLED INJECTIONS

8.3.2.2.2.2.2 VIAL

8.3.2.2.2.3 EYE DROPS

8.3.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.3.2.2.2.5 OTHERS

8.4 SODIUM ACETYLATED HYALURONIC ACID

8.4.1 MOLECULAR WEIGHT

8.4.1.1 HIGH MOLECULAR WEIGHT

8.4.1.2 LOW MOLECULAR WEIGHT

8.4.1.3 MEDIUM MOLECULAR WEIGHT

8.4.2 BY TYPE

8.4.2.1 COSMETIC GRADE

8.4.2.1.1 GENDER

8.4.2.1.1.1 FEMALE PRODUCTS

8.4.2.1.1.2 MEN'S PRODUCT

8.4.2.1.2 PRODUCT TYPE

8.4.2.1.2.1 SKIN CARE

8.4.2.1.2.2 MAKEUP

8.4.2.1.2.3 CLEANSING

8.4.2.1.2.4 HAIR CARE

8.4.2.1.2.5 OTHERS

8.4.2.2 PHARMACEUTICAL GRADE

8.4.2.2.1 TYPE

8.4.2.2.1.1 MEDICAL GRADE HYALURONIC ACID

8.4.2.2.1.2 INJECTION GRADE HYALURONIC ACID

8.4.2.2.2 PRODUCT TYPE

8.4.2.2.2.1 TOPICAL PREPARATIONS

8.4.2.2.2.2 INTRA-ARTICULAR INJECTION

8.4.2.2.2.2.1 PREFILLED INJECTIONS

8.4.2.2.2.2.2 VIAL

8.4.2.2.2.3 EYE DROPS

8.4.2.2.2.4 ORAL PHARMACEUTICAL PREPARATIONS

8.4.2.2.2.5 OTHERS

9 ASIA PACIFIC HYALURONIC ACID MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 AESTHETICS

9.3 OSTEOARTHRITIS

9.4 COSMETICS

9.5 OPHTHALMOLOGY

9.6 PHARMACEUTICAL API

9.7 OTHERS

10 ASIA PACIFIC HYALURONIC ACID MARKET, BY END USER

10.1 OVERVIEW

10.2 DERMATOLOGY CLINICS

10.3 COSMETIC SURGERY CENTERS

10.4 MEDICAL SPAS AND BEAUTY CENTERS

10.5 OTHERS

11 ASIA PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL PHARMACY

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

12 ASIA PACIFIC HYALURONIC ACID MARKET, BY REGION

12.1 ASIA-PACIFIC

12.1.1 JAPAN

12.1.2 CHINA

12.1.3 SOUTH KOREA

12.1.4 INDIA

12.1.5 AUSTRALIA

12.1.6 SINGAPORE

12.1.7 THAILAND

12.1.8 MALAYSIA

12.1.9 INDONESIA

12.1.10 PHILIPPINES

12.1.11 REST OF ASIA-PACIFIC

13 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 FIDIA FARMACEUTICI S.P.A. (2022)

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 ABBVIE INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS

15.3 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

15.3.1 COMPANY SNAPSHOT

15.3.2 COMPANY SHARE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENTS

15.4 GALDERMA

15.4.1 COMPANY SNAPSHOT

15.4.2 COMPANY SHARE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 LG CHEM (2022)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ABBOTT (2022)

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENTS

15.7 ANIKA THERAPEUTICS, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 COMPANY SHARE ANALYSIS

15.7.4 PRODUCT PORTFOLIO

15.7.5 RECENT DEVELOPMENTS

15.8 BIOSCIENCE GMBH

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENT

15.9 BIOXIS PHARMACEUTICALS

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENTS

15.1 BIOIBERICA S.A.U

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BOHUS BIOTECH AB

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENTS

15.12 BRICKELL MEN'S PRODUCTS

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENT

15.13 CONTIPRO A.S.

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENTS

15.14 FILLMED

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 GENESIS

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 HUONS

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENTS

15.17 KEWPIE CORPORATION

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENTS

15.18 LIFECORE BIOMEDICAL, INC.(2022)

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 MERZ NORTH AMERICA, INC. (A SUBSIDIARY OF MERZ PHARMA)

15.19.1 COMPANY SNAPSHOT

15.19.2 PRODUCT PORTFOLIO

15.19.3 RECENT DEVELOPMENTS

15.2 PROLLENIUM MEDICAL TECHNOLOGIES

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 RIVER PHARMA S.R.L.

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

15.22 SHANDONG TOPSCIENCE BIOTECH CO., LTD.

15.22.1 COMPANY SNAPSHOT

15.22.2 PRODUCT PORTFOLIO

15.22.3 RECENT DEVELOPMENTS

15.23 STANFORD CHEMICALS OWNED BY OCEANIA INTERNATIONAL LLC,

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENTS

15.24 SYMATESE

15.24.1 COMPANY SNAPSHOT

15.24.2 PRODUCT PORTFOLIO

15.24.3 RECENT DEVELOPMENTS

15.25 TEOXANE

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 VIRCHOW BIOTECH

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

Список таблиц

TABLE 1 U.S. AESTHETIC PLASTIC SURGERY PROCEDURES COUNT IN 2021 AND 2020:

TABLE 2 REQUIRED TIME, NUMBER OF TREATMENTS, REST TIME

TABLE 3 ASIA PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 4 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 6 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 7 ASIA PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 8 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 10 ASIA PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 11 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 12 ASIA PACIFIC HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 13 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 15 ASIA PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 16 ASIA PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 17 ASIA PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 18 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 19 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 21 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 23 ASIA PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 24 ASIA PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 25 ASIA PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 ASIA PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 27 ASIA PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 29 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 30 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 31 ASIA PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 ASIA PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 33 ASIA PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 35 ASIA PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 ASIA PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 ASIA PACIFIC HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 38 ASIA PACIFIC AESTHETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 ASIA PACIFIC OSTEOARTHRITIS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 40 ASIA PACIFIC COSMETICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 ASIA PACIFIC OPHTHALMOLOGY IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 ASIA PACIFIC PHARMACEUTICAL API IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 ASIA PACIFIC OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 44 ASIA PACIFIC HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 45 ASIA PACIFIC DERMATOLOGY CLINICS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 ASIA PACIFIC COSMETIC SURGERY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 ASIA PACIFIC MEDICAL SPAS AND BEAUTY CENTERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 ASIA PACIFIC OTHERS IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 ASIA PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 50 ASIA PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 ASIA PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 ASIA PACIFIC DIRECT TENDER IN HYALURONIC ACID MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 ASIA-PACIFIC HYALURONIC ACID MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 54 ASIA-PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 55 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 56 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 57 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 58 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 59 ASIA-PACIFIC COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 60 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 62 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 63 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 65 ASIA-PACIFIC PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 66 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 67 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 68 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 69 ASIA-PACIFIC HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 70 ASIA-PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 71 ASIA-PACIFIC SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 72 ASIA-PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 73 ASIA-PACIFIC COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 74 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 75 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 76 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 77 ASIA-PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 78 ASIA-PACIFIC HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 ASIA-PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 80 ASIA-PACIFIC COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 ASIA-PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 82 ASIA-PACIFIC PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 84 ASIA-PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 85 ASIA-PACIFIC SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 86 ASIA-PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 87 ASIA-PACIFIC COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 88 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 89 ASIA-PACIFIC PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 ASIA-PACIFIC INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 91 ASIA-PACIFIC HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 92 ASIA-PACIFIC HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 93 ASIA-PACIFIC HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 94 ASIA-PACIFIC RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 95 JAPAN HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 96 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 97 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 98 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 99 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 100 JAPAN COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 101 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 102 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 103 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 104 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 106 JAPAN PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 107 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 109 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 110 JAPAN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 111 JAPAN SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 112 JAPAN SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 JAPAN COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 114 JAPAN COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 115 JAPAN PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 116 JAPAN PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 117 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 118 JAPAN HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 119 JAPAN HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 120 JAPAN COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 121 JAPAN COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 JAPAN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 JAPAN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 JAPAN INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 125 JAPAN SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 126 JAPAN SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 127 JAPAN COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 128 JAPAN COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 129 JAPAN PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 130 JAPAN PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 JAPAN INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 JAPAN HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 133 JAPAN HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 134 JAPAN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 135 JAPAN RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 136 CHINA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 137 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 138 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 140 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 141 CHINA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 142 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 143 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 144 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 145 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 147 CHINA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 148 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 150 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 151 CHINA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 152 CHINA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 153 CHINA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 154 CHINA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 155 CHINA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 156 CHINA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 157 CHINA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 158 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 159 CHINA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 160 CHINA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 CHINA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 162 CHINA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 163 CHINA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 164 CHINA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 165 CHINA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 166 CHINA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 167 CHINA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 168 CHINA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 169 CHINA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 170 CHINA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 171 CHINA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 172 CHINA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 173 CHINA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 CHINA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 175 CHINA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 176 CHINA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 177 SOUTH KOREA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 178 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 179 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 180 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 181 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 182 SOUTH KOREA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 183 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 185 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 186 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 187 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 188 SOUTH KOREA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 189 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 191 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 192 SOUTH KOREA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 193 SOUTH KOREA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 194 SOUTH KOREA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 195 SOUTH KOREA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 196 SOUTH KOREA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 198 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 200 SOUTH KOREA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 201 SOUTH KOREA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 202 SOUTH KOREA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 203 SOUTH KOREA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 SOUTH KOREA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 SOUTH KOREA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 SOUTH KOREA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 SOUTH KOREA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 208 SOUTH KOREA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 SOUTH KOREA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 210 SOUTH KOREA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 212 SOUTH KOREA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 213 SOUTH KOREA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 SOUTH KOREA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 SOUTH KOREA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 SOUTH KOREA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 217 SOUTH KOREA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 218 INDIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 219 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 220 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 222 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 223 INDIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 224 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 225 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 226 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 227 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 228 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 229 INDIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 230 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 231 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 232 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 233 INDIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 234 INDIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 235 INDIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 236 INDIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 237 INDIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 238 INDIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 239 INDIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 240 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 241 INDIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 242 INDIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 243 INDIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 244 INDIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 245 INDIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 246 INDIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 247 INDIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 248 INDIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 249 INDIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 250 INDIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 251 INDIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 INDIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 253 INDIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 INDIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 255 INDIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 256 INDIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 INDIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 258 INDIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 259 AUSTRALIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 260 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 261 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 263 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 264 AUSTRALIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 265 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 266 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 267 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 268 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 270 AUSTRALIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 271 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 273 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 274 AUSTRALIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 275 AUSTRALIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 276 AUSTRALIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 277 AUSTRALIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 278 AUSTRALIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 279 AUSTRALIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 280 AUSTRALIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 282 AUSTRALIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 283 AUSTRALIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 284 AUSTRALIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 285 AUSTRALIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 286 AUSTRALIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 AUSTRALIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 288 AUSTRALIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 289 AUSTRALIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 290 AUSTRALIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 291 AUSTRALIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 292 AUSTRALIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 293 AUSTRALIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 294 AUSTRALIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 AUSTRALIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 AUSTRALIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 AUSTRALIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 298 AUSTRALIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 299 AUSTRALIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 300 SINGAPORE HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 301 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 302 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 303 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 304 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 305 SINGAPORE COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 306 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 307 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 308 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 309 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 310 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 311 SINGAPORE PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 312 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 313 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 314 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 315 SINGAPORE HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 316 SINGAPORE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 317 SINGAPORE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 SINGAPORE COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 319 SINGAPORE COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 320 SINGAPORE PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 321 SINGAPORE PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 323 SINGAPORE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 324 SINGAPORE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 325 SINGAPORE COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 326 SINGAPORE COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 SINGAPORE PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 328 SINGAPORE PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 329 SINGAPORE INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 SINGAPORE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 331 SINGAPORE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 332 SINGAPORE COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 333 SINGAPORE COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 SINGAPORE PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 SINGAPORE PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 336 SINGAPORE INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 SINGAPORE HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 338 SINGAPORE HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 339 SINGAPORE HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 340 SINGAPORE RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 341 THAILAND HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 342 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 343 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 345 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 346 THAILAND COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 347 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 348 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 349 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 350 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 351 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 352 THAILAND PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 353 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 354 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 355 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 356 THAILAND HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 357 THAILAND SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 358 THAILAND SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 359 THAILAND COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 360 THAILAND COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 361 THAILAND PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 362 THAILAND PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 363 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 364 THAILAND HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 365 THAILAND HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 THAILAND COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 367 THAILAND COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 368 THAILAND PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 369 THAILAND PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 370 THAILAND INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 371 THAILAND SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 372 THAILAND SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 373 THAILAND COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 374 THAILAND COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 375 THAILAND PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 376 THAILAND PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 377 THAILAND INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 378 THAILAND HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 379 THAILAND HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 380 THAILAND HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 381 THAILAND RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 382 MALAYSIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 383 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 384 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 386 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 387 MALAYSIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 388 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 389 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 390 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 391 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 392 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 393 MALAYSIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 394 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 395 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 396 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 397 MALAYSIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 398 MALAYSIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 399 MALAYSIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 400 MALAYSIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 401 MALAYSIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 402 MALAYSIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 403 MALAYSIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 404 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 405 MALAYSIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 406 MALAYSIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 407 MALAYSIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 408 MALAYSIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 409 MALAYSIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 410 MALAYSIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 411 MALAYSIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 412 MALAYSIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 413 MALAYSIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 414 MALAYSIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 415 MALAYSIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 416 MALAYSIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 417 MALAYSIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 418 MALAYSIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 419 MALAYSIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 420 MALAYSIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 421 MALAYSIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 422 MALAYSIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 423 INDONESIA HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 424 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 425 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 426 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 427 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 428 INDONESIA COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 429 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 430 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 431 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 432 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 433 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 434 INDONESIA PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 435 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 436 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 437 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 438 INDONESIA HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 439 INDONESIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 440 INDONESIA SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 441 INDONESIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 442 INDONESIA COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 443 INDONESIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 444 INDONESIA PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 445 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 446 INDONESIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 447 INDONESIA HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 448 INDONESIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 449 INDONESIA COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 450 INDONESIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 451 INDONESIA PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 452 INDONESIA INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 453 INDONESIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 454 INDONESIA SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 455 INDONESIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 456 INDONESIA COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 INDONESIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 458 INDONESIA PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 459 INDONESIA INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 INDONESIA HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 461 INDONESIA HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 462 INDONESIA HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 463 INDONESIA RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 464 PHILIPPINES HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

TABLE 465 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 466 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 467 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 468 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 469 PHILIPPINES COSMETIC GRADE IN HYALURONIC ACID MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)

TABLE 470 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 471 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 472 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (ASP IN USD)

TABLE 473 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 474 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 475 PHILIPPINES PHARMACEUTICAL GRADE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 476 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 477 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME IN MILLION UNITS)

TABLE 478 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD)

TABLE 479 PHILIPPINES HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 480 PHILIPPINES SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 481 PHILIPPINES SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 482 PHILIPPINES COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 483 PHILIPPINES COSMETIC GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 484 PHILIPPINES PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 485 PHILIPPINES PHARMACEUTICAL GRADE SODIUM HYALURONATE IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 486 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 487 PHILIPPINES HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 488 PHILIPPINES HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 489 PHILIPPINES COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 490 PHILIPPINES COSMETIC GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 491 PHILIPPINES PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 492 PHILIPPINES PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 493 PHILIPPINES INTRA-ARTICULAR INJECTION IN PHARMACEUTICAL GRADE HYDROLYZED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 494 PHILIPPINES SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY MOLECULAR WEIGHT, 2021-2030 (USD MILLION)

TABLE 495 PHILIPPINES SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 496 PHILIPPINES COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY GENDER, 2021-2030 (USD MILLION)

TABLE 497 PHILIPPINES COSMETIC GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 498 PHILIPPINES PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 499 PHILIPPINES PHARMACEUTICAL GRADE SODIUM ACETYLATED HYALURONIC ACID IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 500 PHILIPPINES INTRA-ARTICULAR INJECTION IN HYALURONIC ACID MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 501 PHILIPPINES HYALURONIC ACID MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 502 PHILIPPINES HYALURONIC ACID MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 503 PHILIPPINES HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 504 PHILIPPINES RETAIL SALES IN HYALURONIC ACID MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 505 REST OF ASIA-PACIFIC HYALURONIC ACID MARKET, BY GRADE, 2021-2030 (USD MILLION)

Список рисунков

FIGURE 1 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC HYALURONIC ACID MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC HYALURONIC ACID MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC HYALURONIC ACID MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC HYALURONIC ACID MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC HYALURONIC ACID MARKET: DBMR POSITION GRID

FIGURE 8 ASIA PACIFIC HYALURONIC ACID MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 ASIA PACIFIC HYALURONIC ACID MARKET: END USER COVERAGE GRID

FIGURE 10 ASIA PACIFIC HYALURONIC ACID MARKET: SEGMENTATION

FIGURE 11 RISING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE COSMETIC PROCEDURES IS EXPECTED TO DRIVE THE ASIA PACIFIC HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 12 THE GRADE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC HYALURONIC ACID MARKET FROM 2023 TO 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA PACIFIC HYALURONIC ACID MARKET

FIGURE 14 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, 2022

FIGURE 15 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, 2023-2030 (USD MILLION)

FIGURE 16 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, CAGR (2023-2030)

FIGURE 17 ASIA PACIFIC HYALURONIC ACID MARKET: BY GRADE, LIFELINE CURVE

FIGURE 18 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, 2022

FIGURE 19 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, 2023-2030 (USD MILLION)

FIGURE 20 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 21 ASIA PACIFIC HYALURONIC ACID MARKET: BY TYPE, LIFELINE CURVE

FIGURE 22 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, 2022

FIGURE 23 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 ASIA PACIFIC HYALURONIC ACID MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, 2022

FIGURE 27 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 ASIA PACIFIC HYALURONIC ACID MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 ASIA PACIFIC HYALURONIC ACID MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 ASIA-PACIFIC HYALURONIC ACID MARKET: SNAPSHOT (2022)

FIGURE 35 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2022)

FIGURE 36 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 ASIA-PACIFIC HYALURONIC ACID MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 ASIA-PACIFIC HYALURONIC ACID MARKET: GRADE (2023-2030)

FIGURE 39 ASIA PACIFIC HYALURONIC ACID MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

The Asia-Pacific Hyaluronic Acid Market is projected to grow at a CAGR of 7.3% during the forecast period by 2030.
The future market value of the Asia-Pacific Hyaluronic Acid Market is expected to reach USD 2,584.42 million by 2030.
The major players in the Asia-Pacific Hyaluronic Acid Market are Fidia Farmaceutici S.p.A., AbbVie., Bloomage Biotechnology Co., Ltd., GALDERMA, LG Chem, Anika Therapeutics, Inc., Abbott, VIRCHOW BIOTECH, Kewpie Corporation, Merz North America, Inc., etc.
The countries covered in the Asia-Pacific Hyaluronic Acid Market are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and rest of Asia-Pacific.